Vitamin D and skeletal muscle strength and endurance in COPD

European Respiratory Journal

Volumn 41, Issue 2, 2013, Pages 309-316

  Jackson, Abigail S ^a   Shrikrishna, Dinesh ^a   Kelly, Julia L ^a   Hart, Nicholas ^b   Moxham, John ^c   Polkey, Michael I ^a   Kemp, Paul ^a   Hopkinson, Nicholas S ^a  

^a Imperial College ^*  (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Fibre type; Magnetic stimulation; Muscle; Quadriceps; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; MESSENGER RNA; MYOGENIC FACTOR; MYOSIN HEAVY CHAIN ALPHA; PARATHYROID HORMONE; PREDNISONE; VITAMIN D;

25 HYDROXYCOLECALCIFEROL BLOOD LEVEL; ADULT; AGED; ARTICLE; BONE STRENGTH; CALCITRIOL BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENDURANCE; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MAGNETIC STIMULATION; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE EXCITATION; MUSCLE STRENGTH; PARATHYROID HORMONE BLOOD LEVEL; PHYSICAL CAPACITY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; REPEAT PROCEDURE; VITAMIN BLOOD LEVEL;

AGED; ALGORITHMS; BIOPSY; CALCIFEDIOL; CALCITRIOL; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; PARATHYROID HORMONE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84873376848     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00043112     Document Type: Article

References (37)

1. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62: 115-120.
2. Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012; 40: 1115-1122.
3. Jackson AS, Hopkinson N. Skeletal muscle in chronic obstructive pulmonary disease. Clin Pulm Med 2009; 16: 61-67.
4. Stewart JW, Alekel DL, Ritland LM, et al. Serum 25-hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women. Menopause 2009; 16: 1093-1101.
5. Zamboni M, Zoico E, Tosoni P, et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol 2002; 57: M7-M11.
6. Dhesi JK, Bearne LM, Moniz C, et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 2002; 17: 891-897.
7. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: A meta-analysis. JAMA 2004; 291: 1999-2006.
8. Kalyani RR, Stein B, Valiyil R, et al. Vitamin D treatment for the prevention of falls in older adults: systematic review and metaanalysis. J Am Geriatr Soc 2010; 58: 1299-1310.
9. Roth SM, Zmuda JM, Cauley JA, et al. Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol A Biol Sci Med Sci 2004; 59: 10-15.
10. Geusens P, Vandevyver C, Vanhoof J, et al. Quadriceps and grip strength are related to vitamin D receptor genotype in elderly nonobese women. J Bone Miner Res 1997; 12: 2082-2088.
11. Hopkinson NS, Li KW, Kehoe A, et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr 2008; 87: 385-390.
12. de Batlle J, Romieu I, Anto JM, et al. Dietary habits of firstly admitted Spanish COPD patients. Respir Med 2009; 103: 1904-1910.
13. Donaldson GC, Wilkinson TM, Hurst JR, et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 446-452.
14. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010; 65: 215-220.
15. Endo I, Inoue D, Mitsui T, et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003; 144: 5138-5144.
16. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
17. Dipietro L, Caspersen CJ, Ostfeld AM, et al. A survey for assessing physical activity among older adults. Med Sci Sports Exerc 1993; 25: 628-642.
18. Schols AM, Wouters EF, Soeters PB, et al. Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 53: 421-424.
19. Hopkinson NS, Nickol AH, Payne J, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 395-399.
20. Swallow EB, Gosker HR, Ward KA, et al. A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans. J Appl Physiol 2007; 103: 739-746.
21. Yoshikawa S, Nakamura T, Tanabe H, et al. Osteomalacic myopathy. Endocrinol Jpn 1979; 26: 65-72.
22. Sorensen OH, Lund B, Saltin B, et al. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) 1979; 56: 157-161.
23. Sato Y, Iwamoto J, Kanoko T, et al. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: A randomized controlled trial. Cerebrovasc Dis 2005; 20: 187-192.
24. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986; 7: 434-448.
25. Boland R, de Boland AR, Marinissen MJ, et al. Avian muscle cells as targets for the secosteroid hormone 1,25-dihydroxy-vitamin D3. Mol Cell Endocrinol 1995; 114: 1-8.
26. Vazquez G, de Boland AR, Boland R. Stimulation of Ca2+ releaseactivated Ca2+ channels as a potential mechanism involved in nongenomic 1,25(OH)2-vitamin D3-induced Ca2+ entry in skeletal muscle cells. Biochem Biophys Res Commun 1997; 239: 562-565.
27. Ronda AC, Buitrago C, Colicheo A, et al. Activation of MAPKs by 1alpha,25(OH)2-Vitamin D3 and 17beta-estradiol in skeletal muscle cells leads to phosphorylation of Elk-1 and CREB transcription factors. J Steroid Biochem Mol Biol 2007; 103: 462-466.
28. Forli L, Bjortuft O, Boe J. Vitamin D status in relation to nutritional depletion and muscle function in patients with advanced pulmonary disease. Exp Lung Res 2009; 35: 524-538.
29. Ebeling PR, Yergey AL, Vieira NE, et al. Influence of age on effects of endogenous 1,25-dihydroxyvitamin D on calcium absorption in normal women. Calcified Tissue Int 1994; 55: 330-334.
30. Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest 2009; 135: 173-180.
31. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 2006; 174: 886-893.
32. Mui TS, Man JM, McElhaney JE, et al. Telomere length and chronic obstructive pulmonary disease: evidence of accelerated aging. J Am Geriatr Soc 2009; 57: 2372-2374.
33. Haussler MR, Haussler CA, Whitfield GK, et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the ''Fountain of Youth'' to mediate healthful aging. J Steroid Biochem Mol Biol 2010; 121: 88-97.
34. Richards JB, Valdes AM, Gardner JP, et al. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr 2007; 86: 1420-1425.
35. Bischoff-Ferrari HA, Borchers M, Gudat F, et al. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004; 19: 265-269.
36. Ebeling PR, Sandgren ME, DiMagno EP, et al. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. J Clin Endocrinol Metabol 1992; 75: 176-182.
37. Sahota O, Mundey MK, San P, et al. Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 2006; 17: 1013-1021.